Diane Sahr has more than twenty years of clinical research and cost effectiveness research experience and has a unique understanding of healthcare in that she has led evidence-based medicine efforts in all sectors of the healthcare delivery system including hospitals, clinics, payers, and the medical device industry. As a clinical leader, Diane has overseen the design and execution of more than 50 investigational and post-market global clinical trials and has achieved a greater than 90% success in publication of the evidence. Diane has device experience in multiple therapeutic areas including cardiology, neurology, orthopedics and urology.
"Diane’s personal passion for strategic trial design as well as her reputation for trial execution, brings unique value to MMD’s customers," said Ryan Wilson, General Manager, MMD. "She brings a keen sense of early data interpretation and its relevance when evaluating products in feasibility stages and identifying evidence needs. These skills will be valuable assets for our clients, helping ensure that their trials are a success."
The addition of Diane Sahr, who will provide strategic consulting in the design and implementation of trials, demonstrates a commitment to add depth in medical device expertise for the benefit of its Sponsors. With additional knowledge experts in this sector, Medpace Medical Device and Medpace are poised to bring expertise to the design of medical device clinical trials on a global basis.